|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales - services | |||||
| Product | |||||
| Total revenue | |||||
| Cost of sales | |||||
| Cost of sales - services | |||||
| Product | |||||
| Cost of sales | |||||
| Cost of sales - services | |||||
| Product | |||||
| Impairment loss on intangible assets | |||||
| Depreciation and amortization | |||||
| Cost of sales | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Sales and marketing | |||||
| Operating expenses: | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Total selling, general and administrative expenses | |||||
| Goodwill impairment | |||||
| Impairment loss on intangible assets | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income | |||||
| Interest expense | |||||
| Loss before income taxes | |||||
| Benefit from (provision for) income taxes | |||||
| Net loss | |||||
| Net loss per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...